FIELD: pharmacology.
SUBSTANCE: invention refers to pharmacology, namely to a preparation for stimulating anti-tumor immunity or therapy of oncological diseases. Preparation for stimulating anti-tumor immunity or therapy of oncological diseases is characterized by that the main component contains a mixture of native or inactivated corpuscular antigens obtained by at least three culture strains of pale treponema belonging to different antigen groups of the agent. Method for producing the preparation involves preparation of inoculum of at least three strains of culture treponemas, production of biomass of microbes in a liquid nutrient medium, concentration of the obtained microbial suspensions, thermal inactivation of the concentrated native suspensions, their conservation and purification, followed by mixing. Method for stimulating anti-tumor immunity includes parenteral administration of the preparation in a pharmaceutically acceptable amount. Method of oncological diseases therapy includes parenteral administration of the preparation in a pharmaceutically acceptable amount.
EFFECT: above described invention expands the range of immunomodulatory agents with anti-tumor activity.
19 cl, 1 dwg, 14 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
POLYVALENT CORPUSCULAR ANTIGEN FOR PRODUCTION OF MEDICAL AND PREVENTIVE BIOLOGICAL PRODUCTS FOR BRUCELLOSIS | 2006 |
|
RU2330681C1 |
TESTICULAR VACCINE AS AN ANTITUMOUR PROPHYLACTIC AGENT | 2021 |
|
RU2784803C1 |
PROTEIN-PEPTIDE ANTITUMOR COMPOSITION, CELL PREPARATION ACTIVATED THEREWITH AND METHOD FOR TUMOR PROPHYLAXIS OR TREATMENT | 2004 |
|
RU2283129C1 |
VACCINE COMPOSITIONS, METHODS FOR APPLICATION THEREOF IN MELANOMA PREVENTION AND TREATMENT, AND GENETIC CONSTRUCTIONS FOR OBTAINING ACTIVE SUBSTANCES OF COMPOSITION | 2006 |
|
RU2333767C2 |
METHOD FOR ACTIVATION OF CYTOTOXIC LYMPHOCYTES | 2019 |
|
RU2751837C2 |
POLYVALENT CATTLE VACCINE AGAINST ANAEROBIC ENTEROTOXEMIA AND METHOD OF USING IT | 2017 |
|
RU2699035C2 |
VACCINE AND METHOD FOR INCREASING IMMUNOGENICITY AND SPECIFIC ACTIVITY OF INFECTION PREVENTION AGENTS | 2020 |
|
RU2741834C1 |
CELL LINE OF HUMAN KIDNEY CANCER IBGVAT R 6 | 2014 |
|
RU2573940C1 |
MIXED VACCINE AGAINST ROTA-, CORONA-, HERPESVIRAL AND ESCHERICHIA DIARRHEA IN NEWBORN CALVES | 1999 |
|
RU2145236C1 |
CELL LINE OF HUMAN KIDNEY CANCER IBGVAT R 27 | 2014 |
|
RU2573938C1 |
Authors
Dates
2016-09-20—Published
2015-04-24—Filed